Inmune Bio, Inc. (INMB) › Capital ExpendituresInmune Bio, Inc. (INMB) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.Fiscal YearCapital ExpendituresChange YoY2025$1.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share